Rangwala Reshma - Insider Non-Derivative Transactions at Karyopharm Therapeutics Inc. (KPTI) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Apr 22, 2024, Rangwala Reshma's relationship to Karyopharm Therapeutics Inc. (KPTI) is Officer (EVP & Chief Medical Officer), and currently has 342,931 shares of Common Stock, and 349,720 shares of Common.

The the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KPTI insiders.

Data Source: SEC.
Rangwala Reshma - Insider Non-Derivative Transactions of KPTI Common Stock
Rangwala Reshma - Insider Non-Derivative Transactions of KPTI Common
Rangwala Reshma - Insider Non-Derivative Transactions at KPTI
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Apr 23, 2024 Sell -- (Common Stock) 6789 1.17 342931
Mar 2, 2024 Sell -- (Common) 5969 1.2 349720
Mar 1, 2024 Sell -- (Common) 15667 1.17 355689
Feb 29, 2024 Acquisition -- (Common Stock) 198959 0 371356
Jan 25, 2024 Acquisition -- (Common Stock) 14167 0 172397
Apr 21, 2023 Sell -- (Common Stock) 6655 4.05 158230
Apr 21, 2023 Sell -- (Common Stock) 115 4.03 164885
Mar 1, 2023 Acquisition -- (Common Stock) 100000 0 165000